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iABSTRACT
Many therapeutics administered for some of the most devastating illnesses can be
toxic and result in unwanted side effects. Recent developments have been made in an
alternative treatment method, called gene therapy. Gene therapy has potential to rectify
the genetic defects that cause a broad range of diseases. Many diseases, such as cancer,
cystic fibrosis, and acquired immunodeficiency (AIDS) already have gene therapy
protocols that are currently in clinical trials. Finding a non-toxic and efficient gene
transfer method has been a challenge. Viral vectors are effective at transgene delivery
however potential for insertion mutagenesis and activation of immune responses raises
concern. For this reason, non-viral vectors have been investigated as a safer alternative to
viral-mediated gene delivery. Non-viral vectors are also easy to prepare and scalable, but
are limited by low transgene delivery efficacies and high cytotoxicity at effective
therapeutic dosages. Thus, there is a need for a non-toxic non-viral vector with high
transgene efficacies. In addition to the hurdles in finding a material for gene delivery,
large-scale production of pharmaceutical grade DNA for gene therapy is needed. Current
methods can be labor intensive, time consuming, and use toxic chemicals. For this
reason, an efficient and safe method to collect DNA is needed. One material that is
currently being explored is the hydrogel. Hydrogels are a useful subclass of biomaterials,
with a wide variety of applications. This class of biomaterials can carry up to a thousand
times their weight in water, and are biocompatible. At smaller dimensions, referred to as
micro- and nanogels, they are very useful for many biomedical applications because of
their size and ability to swell.
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Based on a previously synthesized hydrogel, and due to the advantages of smaller
dimension in biomedical applications, we have synthesized aminoglycoside antibiotic
based nanogels and microgels. Microgels and nanogels were synthesized following a ring
opening polymerization of epoxide-containing crosslinkers and polyamine-containing
monomers. The nanogels were screened for their cytocompatibilities and transfection
efficacies, and were compared to polyethylenimine (PEI), a current standard for polymer-
mediated transgene delivery. Nanogels demonstrated minimal to no toxicity to the cell
line used in the study even at high concentrations. Due to the emerging need for large-
scale production of DNA, microgels were evaluated for their binding capacity to plasmid
DNA. Future work with the aminoglycoside antibiotic-based nanogels and microgels
developed in this study will involve optimization of nanogels and microgels to facilitate
in better transgene delivery and plasmid DNA binding, respectively.
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1Chapter 1
INTRODUCTION
1.1 Introduction to Hydrogels.
Hydrogels are an attractive subclass of biomaterials with a wide variety of
applications. They have been used in soft contact lenses, as bioadhesives for wound
treatment, as coatings on catheters, pills, capsules, and even inside the capillary wall in
capillary electrophoresis. In sheet form, hydrogels have been used as a reservoir in
transdermal drug delivery patches and 2D electrophoresis gels [1]. Hydrogels are three-
dimensional hydrophilic polymer networks that have the ability to swell while
maintaining an intact structure. These hydrophilic polymer networks can absorb up to
thousands of times their dry weight in water [2]. Their high water content makes them
biocompatible.
Hydrogels can be fabricated over a wide range of sizes, and at smaller dimensions
exhibit desirable qualities. Hydrogels in the micron range are referred to as microgels,
and in the nanoscale are nanogels. These smaller dimension hydrogels have been studied
extensively in the biomedical field, because of their tunable chemical and physical
structure, good mechanical properties, high water content, and biocompatibility [3].
Microgels and nanogels are generally made from with natural or synthetic polymers.
Common natural polymers used are chitosan and alginate, and synthetic are
polyethylenimine, poly(vinyl) alcohol, poly(vinyl) pyrrolidone, poly(ethylene)glycol,
poly-N-isoprpylacrylimide [4]. Furthermore, the reduced size of nanogels make them
2highly attractive for tissue regeneration and for drug delivery because they can reach
specific sites in the body not easily accessible by microgels and macroscopic hydrogels.
1.2 Nanogels as Drug / Gene Delivery Vehicles
1.2.1 Considerations in Designing Nanocarriers. The main goal in drug
delivery is to unload an effective dose of therapeutic agent at the targeted site, while
minimizing the adverse side effects. Therefore, as a nanocarrier design engineer it is
important to understand the design features that are beneficial for effective drug delivery.
Some of the characteristics of an ideal nanocarrier are that they have (1) longevity in the
blood, (2) co-loading capabilities, (3) stimuli-sensitivity, (4) sight-specific delivery, as
shown in figure 1.
Figure 1. Schematic representation of ideal nanocarrier
for gene / drug delivery. Based on [7].
One of important property in a good delivery vehicle is the ability to circulate in
the blood for a long time. Nanocarriers face many hurdles as they travel to their
destination, such as opsonization and clearance by the reticuloendothelial system (RES).
3Opsonization is the immune response that results from the adsorption of serum proteins
known as opsonins [5]. Surface properties can be optimized to avoid opsonization. It has
been demonstrated that vehicles that are uncharged and have hydrogen bond donor
groups can reduce protein adsorption [6]. Another surface modification that increases
longevity in blood is the use of poly(ethylene)glycol (PEG) or other hydrophilic polymers
(polyvinyl pyrrolidone, polyacryl amide, polyhydrazones, polymorpholines) [7].
Modification of nanocarriers with these polymers prevents interaction with solutes and
reduction of uptake by the RES. The additional benefit of nanocarriers with long-
circulation is that they can participate in a phenomenon called the enhanced permeability
and retention effect. By this phenomena, particles can slowly accumulate in solid tumors
due to the defective vasculature, resulting in passive targeting.
Another design aspect to consider is the ability to load multiple therapeutic
agents. For instance, in comparison to a single drug, combination chemotherapy regimens
in cancer treatment have shown improved anticancer activity compared to a single drug
[8]. Combination therapies improve drug solubility and bioavailability and can
potentially prevent multidrug resistance [9].  For these reasons nanocarriers with high
loading capacity and with multifunctional groups are advantageous.
Stimuli-sensitivity in a nanocarriers can further improve efficacy of delivery. One
of the most extensively studied stimuli-sensitive nanocarriers are acid-sensitive carriers,
due to the characteristic excess acidity of tumor regions. In comparison to normal tissues,
tumors typically exhibit a weak acidity with pH of 6.8. Upon cellular uptake, drug-loaded
nanocarriers will be subjected to an intracellular pH of 5.9–6.2 in early endosomes, and
pH of 5.0–5.5 in late endosomes and lysosomes [10]. Thus, nanocarriers responsive to
4these pH alterations may provide an alternative type of targeting strategy to further
improve therapeutic efficacy by cancer site-specific delivery and controlled release.
The ability to tailor a nanocarrier to reach its intended site is advantageous
because it can reduce the accumulation and toxicity in healthy tissues. Many therapeutic
agents delivered systemically pose risk of harsh side effects. One example is the
anticancer drug doxorubicin. This drug is very effective at causing cell death in cancer
cells, however causes significant risk for congestive heart failure [11]. To engineer
specificity to delivery vehicles, vehicles can be coated or conjugated with ligands for a
particular cell surface receptor. Cancer cells commonly over express cell surface
receptors for nutrients and growth factors, such as epidermal growth factor, transferrin,
and folic acid. All have been used for active targeting of delivery vehicles [12]. With the
combination of an optimally engineered nanocarrier, a suitable therapeutic, and an
appropriate disease application, the benefit of a nanocarrier over the equivalent non-
targeted system can be substantial.
1.2.2 Nanogel Swelling Characteristics. One of the unique properties of
nanogels is its capability to swell or collapse in response to environmental stimuli. The
high swelling capacity allows nanogels to load more cargo than normally observed for
other nanosize pharmaceutical carriers such as polymeric micelles, liposomes, and
polymeric nanoparticles. This is because swollen nanogels are mainly comprised of water
and this space provides more room for incorporation of therapeutic molecules [13].
Along with desirable high loading capacity, swelling and collapse of nanogels also
optimize these carriers for effective drug/gene release, based on its response to
environmental stimuli. Understanding the swelling characteristics makes these carriers
5tunable for desired stimuli response. In summary, the two key advantages of swelling
properties in nanogels is their high loading capacity and tunability for responsive
drug/gene release.
It is widely accepted that swelling capacity in nanogels is a balance between a
change in osmotic pressure and the polymer elasticity. The characteristics in nanogel
formulation that govern swelling include cross-linking density, chemical structure and
charge density. Nanogel engineers can tune these properties to swell in presence of
stimuli such as pH, temperature, ions, glucose, etc., and to swell to a desired capacity.
Lower crosslinking density can increase swelling size and lead to homogenous swelling.
In fact, in one study, it was found that high cross-linking reduced swelling size
significantly and lead to inhomogeneous deformation of nanogel [14].
Presence of chemical moieties such as amino groups, carboxylic groups, some
synthetic polymers can give nanogels the stimuli-responsive swelling characteristics. In
pH-responsive nanogels functional groups that are weak acids (carboxylic groups) and
weak bases (amino groups) can ionize in pH values above its pKa, or below its pKb
respectively. Ionization of the functional groups causes the electrostatic repulsion,
thereby increasing the size of the nanogel. As stated in the previous section, pH-
responsive swelling is advantageous because many defective tissues have lower pH
values than normal tissue. Also, beneficial is along the GI tract, pH has drastic change
between the stomach (pH=2) and the intestine (pH= 5-8) [15].
Chemical structure of the nanogel can also influence temperature response. These
types of nanogels are generally made of synthetic polymers such as poly-N-
isopropylacrylamide [16], poly(ethylene oxide-b-propylene oxide-b-ethylene oxide) and
6poly(ethylene oxide)/(d,l-lactic acid-co-glycolic acid) [17]. Molecular weights of these
synthetic polymers can dictate the transition temperature at which the nanogel exhibits
swelling or collapse. One example of this phenomenon is PEG, which a very popular
stabilizing agent. PEG at 2000 Da, which is considered lower molecular weight PEG
moiety, has a transition temperature around 170 – 180°C [18], whereas infinite molecular
weight PEG exhibits transition temperature around 100°C [19]. Swelling occurs in PEG
because when temperature rises, hydrogen bonds between the PEG units in the nanogel
and water molecules break.
1.2.3 Microparticles for DNA purification. With recent developments in gene
therapy, there is an increasing need for large-scale production of pharmaceutical-grade
plasmid DNA. The problem with traditional DNA purification methods, such as
saccharose and cesium chloride–diethidium bromide density gradient ultracentrifugation,
is that they are difficult to scale up, are time-consuming, and often use chemical reagents
that can be harmful for the operator. For this reason, adsorption chromatography is
advantageous because it uses chemicals that are safe and it is scalable. There have been
several chromatographic methods such as size exclusion, hydrophobic interaction,
reversible phase, and anion exchange based particulate supports that have been reported
for purification of DNA [20]. Although, limited research has been done to determine the
efficacy of microgel particles for DNA purification purposes, the cationic property of
many hydrogel particles may make it a good candidate for these applications.
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SYNTHESIS AND EVALUATION OF AMINOGLYCOSIDE-BASED NANOGEL
FOR GENE DELIVERY
2.1 Introduction
As stated in the previous chapter, nanogels are a useful class of drug delivery
vehicles, primarily because of their size and swelling capabilities. If tuned properly,
nanogels can be made to be “intelligent” devices for drug delivery. Intelligent
nanocarriers are devices that respond to environmental stimuli, delivering therapeutics to
their intended sites. Recently, a new class of aminoglycoside antibiotic-based polymers
were synthesized and demonstrated for their transgene efficacy. Cell viability studies
revealed that these polymers were less toxic than 25 kDa pEI, and lead polymers
demonstrated high luciferase expression in transfections studies [21]. Among the
antibiotics analyzed in the study was amikacin-hydrate, as shown in Fig. 2
Figure 2. Structure of amikacin-hydrate
Amikacin is an aminoglycoside used to treat various bacterial infections.
Amikacin works by binding to the bacterial 30S ribosomal subunit, causing misreading of
mRNA, thus leaving the effected bacterium unable to synthesize proteins which are vital
8for its own growth [22]. In the molecular structure of amikacin, there are four primary
amines. Potta et al. [21] synthesized an amikacin-based hydrogel, among others
hydrogels, using ring-opening polymerization between amines of amikacin and epoxides
of poly (ethylene glycol) diglycidyl ether (PEGDE).
Using the chemistry from Potta et al [21], we have developed aminoglycoside-
based nanogels. We hypothesize that amines present on the chemical structure of the
nanogels will give the nanogel cationic properties and expect the nanogels to have the
ability to bind DNA. In this work, we have synthesized three amikacin-based nanogels
with varying cross-linking densities, and evaluated their size, zeta, and cytocompatibility.
Of these three nanogels, we have evaluated one nanogel, referred to herein as AM1, for
its transfection efficacy as a starting point to optimize these nanogels for effective gene
delivery. The cell line used in this experiment is PC3 (prostate cancer cells). Without
optimization, these nanogels have low transfection efficacy, however due to their
minimal to no cytotoxicity even at high treatments demonstrates that they have potential
to be effective nanocarriers for gene and drug delivery purposes. The following
preparation of nanogels is determined as the current best known method for synthesis of
amikacin-based nanogels, and serves as a starting point for its optimization.
2.2 Materials and Methods
2.2.1 Materials. Mineral oil (light), Amikacin hydrate, Acetone, Hexane,
poly(ethyleneglycol) diglycidyl ether (PEGDE), were procured from Sigma Aldrich (St.
Louis, MO) and used as received without any modification.  Evonik ABIL®EM90 was
given as a gift from Dr. Youngbull.
92.2.2 Synthesis of Cationic Nanogels. Nanogels were synthesized via inverse
miniemulsion polymerization [23]. Organic phase (2.2 ml of 10% abil em 90 in mineral
oil) was mixed with aqueous phase (25 mg Amikacin hydrate, 250 µl nanopure water,
and various volumes of PEGDE, see Table 1) using a magnetic stir bar at 850 rpm, 5 min.
Emulsion was ultrasonicated three times at 40% amplitude for 30 cycles 1s on/off, over
ice. Emulsion was spun at 170 rpm, for 10 min in an oil bath maintained at 70oC.
Table 1:
Amine/Epoxide Molar ratio and volume of PEGDE added to make AM1, AM2, AM3
Following polymerization, nanogels were pelleted down by centrifugation (700 g, 2 min)
and the supernatant was discarded. The nanogel pellet was washed twice: once in
acetone, and once in a 1:1 (v/v) acetone/hexane mixture before being dispersed in 11 ml
of nanopure water.
2.2.3 Amine concentration. Reactive primary amines on nanogels were
determined by the ninhydrin assay. Preparation of sample was done by adding 100 µl of
ninhydrin reagent to 200 µl of 1.6 mg/ml AM2 nanogel suspension (dialyzed and
undialyzed). The resulting sample was exposed to boiling water for 10 minutes and then
allowed to cool to room temperature.  Samples were stabilized with 500 µl ethanol before
Sample Molar ratio of
amine/epoxide
Volume of PEGDE
added (µl)
AM1 1:1.5 28.125
AM2 1:2 37.5
AM3 1:3 56.25
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performing absorption measurements at 570 nm using a plate reader (Bio-Tek Synergy
2). Amine content was calculated using a glycine standard curve.
2.2.4 Zeta Potential and Particle Size Determination of Nanogels and
Nanoplexes. The surface charge of the nanogels and nanoplexes was determined using
the Zetasizer Nano ZS (Malvern Instruments Ltd., UK) at a temperature of 25 °C. The
nanoplexes were prepared in nanopure water with increasing pGL 4-5 plasmid
DNA/polymer (w/w) ratios from 1:1.26 to 1:628. The particle size of the nanoplexes was
evaluated by dynamic light scattering measurement. Here, complexes with varying ratios
were measured using the Zetasizer Nano ZS (Malvern Instruments Ltd., UK) at 25 °C.
2.2.5 Cells and cell culturing. PC-3 cells (prostate cancer cell line) were
obtained from the American Type Culture Collection (Manassas, VA). Cells were
cultured in serum containing media (RPMI 1640, 10% FBS, 1% penicillin, 1%
streptomycin) and were grown in an incubator under humidified air containing 5% CO2 at
37°C.
2.2.6 In vitro transfection activity. PC3 cells were seeded in 24 well plate at cell
density of 50,000 cells per well with RPMI medium containing 10% FBS and incubated
at 37 °C for 24 hours. Nanoplexes were prepared at ratios 1:1, 1:2, 1:5, 1:10, and 1:25
with pE-GFP plasmid DNA and equilibrated for 30 min. The cells were then treated with
prepared nanoplexes in serum-free RPMI media. At 6 hours, the medium was replaced
and cells were further incubated with the samples for 48 hours in RPMI containing FBS.
Cells were compared using emissions from fluorescence microscopy (AxioObserver D1,
Carl Zeiss MicroImaging Inc., Germany).
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2.3 Results and Discussion
2.3.1 Nanogel properties. Three formulations of nanogels (AM1, AM2, and
AM3) were synthesized and studied for size, zeta, and amine content. These nanogel
formulations differ only by crosslinker. Table 2 shows the size, zeta potential, and amine
content of undialyzed nanogels. All studies in this document were done with undialyzed
nanogels unless otherwise stated. Size of AM1, AM2, and AM3 all were in the
acceptable range for nanocarriers. Nanogel carriers in the size range of 10–100 nm will
have improved blood circulation time and are permeable tissues such as tumors [24].
AM1 is significantly larger than AM2 and AM3, which maybe an indication of the large
swelling capabilities of AM1. As reported earlier, decreased cross-linking density, as
observed with AM1 leads to larger swelling. Zeta potential was unaffected by cross-
linking density.
Table 2:
Properties of Nanogels
Zeta Potential
(mV) +sd
Average diameter
(nm) +sd
Amine
Content (mM)
AM1 52.16 + 6.60 60.36 +50.64 --
AM2 54.38 + 4.90 43.98 +17.34 83.12
AM3 56.4 + 4.92 42.61 +21.87 --
AM2 was dialyzed and analyzed for size, zeta and amine content. All
characteristics were reduced to half, and standard deviations were decreased significantly.
The average size was 25.44 + 5.53 nm, 27.37 + 2.21 mV, and amine content was 45.07
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mM. From these values, it is understood that dialysis is an important step to remove any
unwanted impurities and to have a controlled and consistent study.
2.3.2 Cytocompatibility of Undialyzed Nanogels. Cytocompatibility of three
nanogel formulations was determined in PC3 cell lines using MTT assay. It was found
that all three nanogels were cytocompatible with PC3 cells for all masses studied. In
comparison to the dead control, the average cell viabilities for AM1, AM2, AM3 are 98.6
+5.3%, 102 + 8.8%, and 99.4 + 8.7%, respectively. Figure 3 shows the cytocompatibility
study of the three nanogels in PC3 cell line.
Figure 3. Cytocompatibility studies for (a) AM1, (b) AM2, and (c) AM3 in PC3 cell line
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2.3.3 Nanoplex Properties and Transfection Efficacy. Stability of a nanoplex is
determined by its surface charge which is indicated by the zeta potential value.  The zeta
value was recorded at 25 °C in nanopure water and is shown in Table 3. Based on these
readings, we can assume nanoplexes formed because only one peak was observed.
Generally, when the complexes do not form, multiple peaks would be observed, each
indicating the zeta potential of the separate entities. Table 3 also shows the surface charge
and size of the nanoplexes made of varying AM1 and pDNA masses.
Table 3:
Zeta potential (mV), hydrodynamic diameter (nm) and polydispersity index of AM1 and
DNA complexes at different weight ratios.
Samples
(polymer:DNA
weight ratios)
Zeta Potential
(mV) +sd
Average diameter
(nm) +sd
AM1:DNA   1.3 : 1 -23.30 +6.23 89.69 + 39.77
AM1:DNA   3.1 : 1 -6.96 +5.01 94.39 + 18.30
AM1:DNA   6.3 : 1 + 13.60 +4.60 --
AM1:DNA   15.7 : 1 + 31.50 +4.21 91.70 + 49.59
AM1:DNA   31.4 : 1 + 27.17 +2.40 38.48 + 2.89
AM1:DNA   62.9 : 1 + 32.60 +2.33 --
AM1:DNA   125.7 : 1 + 36.05 +2.00 --
AM1:DNA   314.3 : 1 + 42.23 +2.09 41.56 + 5.53
AM1:DNA   628.6 : 1 + 46.00 +2.50 52.86 + 4.82
From ratios between 1.3 and 3.1 the nanoplexes are negatively charged, whereas for
ratios of 6.29 and above, the surface charge were found to increase from +13.6 mV to
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+46.0 mV as in Table 3. As the polymer concentration increased, the zeta potential value
also increased. Nanoplexes acquired the positive surface charge from the secondary
ammonium bases present in AM1.
Intact compaction and condensation of pDNA within the polymer was asserted by
the measurement of the particle size by dynamic light scattering performed at 25 °C. The
mean hydrodynamic diameters of the complexes of different weight ratios are given in
Table 3. Size was seen in the range from 38.48 to 94.39 nm. At lower charge and lower
DNA/polymer ratios (1:1.3 to 1:6.3), the size is almost two times larger than
DNA/polymer ratios (1:31.4 to 1:628.6), which exhibit more positive surface charge. As
explained in the previous chapter, swelling of ionizable nanogels are dictated by
electrostatic repulsion. Our results, go against this assertion, in that at a more neutral
state, swelling is occurring.
Fig. 4 shows the transfection efficiency of the AM1 when coupled to DNA in
ratios of 1:10 and 1:25. Nanoplex sample of 1:25 is representative of 1:1 and 1:2.
Figure 4. Fluorescence microscopy images of PC3 cells treated with (i) PEI,
(ii) 1:10 nanoplex, (iii) 1:25 nanoplex, and live control showing transfection efficacies.
Successful transfer is indicated by white spots.
When compared to the control reagent PEI, AM1 showed minimal to no levels of
transfection in PC3 cells. Table 3 shows that at DNA to polymer weight ratios of 1:10,
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nanoplexes are cationic, which is good for uptake by the negatively charged cell surface.
However Table 3 shows the zeta potential of nanoplexes in water, and transfection study
was done in serum-free media, so results are not a conclusive explanation for the limited
uptake seen in 1:10 samples. As observed in the previous section, dialysis may improve
transfection because this would eliminate complexation of DNA with free amines that
may be present in the sample. Additionally, conjugation of the nanogels with a cell
penetrating ligand may also increase uptake.
Conclusion. Thus far, we have synthesized three cationic aminoglycoside
antibiotic-based nanogels with varying crosslinking densities. Due to their positive
surface charge, these nanogels are able to complex with plasmid DNA to form
nanoplexes. In addition to our characterization of the nanogels, we have found that
dialysis can improve purification of nanogels. Purified nanogels may have improved
properties, and load more DNA because complexation with competing free amines would
be avoided. Although these nanogels have not demonstrated effective transgene delivery,
if optimized, can serve as a potential nanocarrier because of their low toxicity profile.
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Chapter 3
PREPARATION AND DNA ADSORPTION ISOTHERM OF AMINOGLYCOSIDE-
BASED MICROGELS
3.1 Introduction
With recent developments in gene therapy, there is an increasing need for large-
scale production of pharmaceutical-grade plasmid DNA. Many diseases, such as cancer,
cystic fibrosis, and acquired immunodeficiency (AIDS) have gene therapy protocols that
are currently in clinical trials.
For this reason, we have developed a novel amino-glycoside based microgel,
which may have the ability to bind high quantities of DNA in adsorption column
chromatography. These microgels use the same chemistry used as in described in the
previous chapter and in Potta et al [21]. It is hypothesized that due to the presence of
primary amines on amikacin, microgels will be cationic and can be neutralized with
anionic pDNA. In this chapter we describe our methodology to synthesize
aminoglycoside antibiotic-based microgels, determine the hydrodynamic diameter and
report preliminary results on its pDNA binding ability.
3.2 Materials and Methods
3.2.1 Materials. Mineral oil (light), Amikacin hydrate, Acetone,
poly(ethyleneglycol) diglycidyl ether (PEGDE), sorbitan monooleate (span 80) were
procured from Sigma Aldrich (St. Louis, MO) and used as received without any
modification.
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3.2.2 Synthesis of Amino-glycoside based Microgel Particles. Microgels were
prepared by suspension polymerization. Aqueous and oil phase were prepared separately.
Aqueous phase was comprised of a homogenous solution of 50 mg of amikacin hydrate,
75 µl of PEGDE and 500 µl of nanopure water. Oil was 80 ml of 1 wt% span 80 in
mineral oil. Aqueous solution was dispensed dropwise at a rate of 10 µl/min and
maintained at 70°C, with constant stirring. Polymerization reaction was carried out for 15
minutes after the last drop. Following polymerization, microgels were pelleted down by
centrifugation (5430 g, 10 min) and the supernatant was discarded. The microgel pellet
was washed twice in roughly 0.5% tween 20 in nanopure water and followed by
nanopure water until solution appeared clear.
3.2.3 DNA Batch Isotherm. pGL4.5 plasmid DNA was transformed into E coli
and expanded, extracted, and purified using a Qiagen Maxi Prep kit according to
manufactures protocols. A solution of 200 µl of pDNA in EB buffer at varying
concentrations (75.75, 227.5, 455, and 910 ng/µl) was combined with ~2mg of
dehydrated microgels in 2 ml eppendorf tubes. The mixture was rotated for at 25°C for
24 hour to allow equilibrium to be reached. Equilibrium plasmid concentration was then
measured by reading the 260 nm absorbance. The amount of adsorbed plasmid, qe, was
calculated by mass balance of supernatant content, before and after equilibrium (Ce), and
experimental data was plotted. Maximum binding capacity (qmax) was obtained from the
best fit of the experimental data to a Langmuir isotherm curve from experiments done in
duplicate.
qe =
max⋅ ⋅ e⋅ e
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3.3 Results and Discussion
3.3.1 Microgel synthesis. Microgel particles were suspended in nanopure water
and allowed to swell for at least 15 minutes before analysis. In swollen state, nanogels
appear to be spherical in shape, as shown in Figure 5. Hydrodynamic diameter was to be
12.6 + 8.18 µm, measured by confocal microscopy.
Figure 5. Image of microgels in nanopure water. Microgels were prepared
in mineral oil using sedimentation polymerization method.
3.3.2 Plasmid Adsorption. Batch adsorption data was measured for the plasmid
adsorbing to novel microgel beads. Microgel beads used in experiment were from 3
batches of beads per experiment synthesized by methods mentioned above. The results
plotted in Fig. 6 show that the solid-phase plasmid concentration against liquid phase
plasmid concentration. All experiments were carried out in EB buffer. The data were fit
to the Langmuir isotherm, yielding an estimated capacity qmax of 35 mg/g.
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Figure 6. Batch Adsorption isotherms for adsorption of plasmid DNA to novel microgel
beads. Experimental data (points) and fitted Langmuir isotherm (line) are for plasmid
binding with 12 µm microgel beads equilibrated for 24h in EB buffer.
3.4 Conclusions. Successful synthesis of aminoglycoside antibiotic-based
microgels was achieved. Microgels made were roughly 12 microns in diameter when
suspended in nanopure water. From preliminary batch adsorption isotherm data,
microgels demonstrates ability to bind to DNA. However many improvements need to be
made to increase loading capacity, in order for this material to be effective for DNA
purification.
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FUTURE WORK
4.1 Chapter 2 Future Work
From size, zeta potential, and amine content results of AM2, we have determined
that AM1 and AM3 need to be purified via dialysis using a 1000 Da MWCO membrane
against water. This will ensure that all contaminants and excess amines, which are
soluble in water, are removed from the nanogel solution. The excess amines may present
a problem in accurate size determination of the nanogel samples. They also can bind to
the DNA occupying binding sites where the nanogel usually binds. With all of the excess
monomer removed from the polymer solution, it is speculated that only the polymer will
bind to the DNA. This could lead to more efficient condensation of the DNA and allow
higher transfection efficacy due to smaller particle sizes. The size, zeta potential, amine
content, and transfection efficacy would have to be re-evaluated with dialyzed nanogels.
Although purifying the nanogels further will only improve cytocompatibility, it would be
beneficial to test the cytocompatibility of dialyzed nanogels at the higher masses to give
higher confidence to the MTT results.
Size and zeta of polyplexes should be repeated in serum-free and serum-
containing media. Understanding the effect of serum free and serum containing media
can explain whether charge of the polyplex is effecting the uptake of polyplex. If charge
is not the culprit, another possibility could be that the nanoplexes are too stable and the
vector is unable to release the pDNA for expression by the cell. In the case that the
charge is not found to be the culprit, altering the formulation to make them degradable
may alleviate this issue. As the nanogel degrades, it is expected to be released from the
carrier, freeing it for expression by the cell. Degradable component must be
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cytocompatible in order to be beneficial. Loading capacity of these vectors needs to be
determined using the gel retardation assay. Polyplexes in ratios between 1:1 to 1:50
would need to be prepared and loaded onto agarose gel. When voltage is applied, the
nanoplex that does not move is considered to be the fully loaded nanoplex.  One
commonly reported item that poses a threat to the toxicity of nanogels is the presence of
surfactant. We currently use 10% abil em 90, which is relatively a large amount. It would
be a good idea to determine whether there is still a presence of the surfactant.
4.2 Chapter 3 Future Work
It would be useful to develop size controlled microparticles of various sizes, and
analyze binding effects based on size. Elution is a pretty important step, which often uses
harsh and toxic chemicals. And, this problem can be exacerbated in large scale
production. Elution of DNA binding beads need to be studied. To determine crosslinking
degree of the microgels, amine content should be determined. This information would
also be valuable if any conjugation for optimization were to be done.
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